MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,636,887 | -24.8% | 413,771 | +8.6% | 0.02% | -21.1% |
| Q2 2023 | $8,829,100 | +13.3% | 380,948 | +13.6% | 0.02% | +5.6% |
| Q1 2023 | $7,793,340 | +65.0% | 335,486 | +3.1% | 0.02% | +50.0% |
| Q4 2022 | $4,721,873 | -38.1% | 325,422 | -18.6% | 0.01% | -42.9% |
| Q3 2022 | $7,623,000 | +20.8% | 399,573 | +15.0% | 0.02% | +31.2% |
| Q2 2022 | $6,313,000 | -47.8% | 347,474 | -27.6% | 0.02% | +23.1% |
| Q1 2022 | $12,100,000 | +54.0% | 480,212 | +68.7% | 0.01% | -23.5% |
| Q4 2021 | $7,857,000 | +9.0% | 284,659 | +27.6% | 0.02% | -5.6% |
| Q3 2021 | $7,205,000 | +31.5% | 223,127 | +24.6% | 0.02% | +20.0% |
| Q2 2021 | $5,478,000 | +5.7% | 179,141 | +5.3% | 0.02% | -16.7% |
| Q1 2021 | $5,181,000 | +168.3% | 170,143 | +74.2% | 0.02% | +157.1% |
| Q4 2020 | $1,931,000 | +96.2% | 97,652 | +29.5% | 0.01% | +40.0% |
| Q3 2020 | $984,000 | +67.1% | 75,412 | +45.4% | 0.01% | +25.0% |
| Q2 2020 | $589,000 | – | 51,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |